Mexiletine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mexiletine" in English language version.

refsWebsite

Global rank English rank

2^nd place

2^nd place

4^th place

4^th place

3semanticscholar.org

11^th place

8^th place

1,712^th place

1,063^rd place

1books.google.com

3^rd place

3^rd place

3,258^th place

2,666^th place

800^th place

676^th place

4,294^th place

6,357^th place

1biospectrumindia.com

low place

low place

biospectrumindia.com

"Lupin announces launch of NaMuscla". www.biospectrumindia.com. Retrieved 2019-06-17.

books.google.com

Canavero S, Bonicalzi V (13 October 2011). Central Pain Syndrome: Pathophysiology, Diagnosis and Management. Cambridge University Press. pp. 286–. ISBN 978-1-107-01021-5.

canada.ca

"Product monograph brand safety updates". Health Canada. February 2024. Retrieved 24 March 2024.

doi.org

Manolis AS, Deering TF, Cameron J, Estes NA (May 1990). "Mexiletine: pharmacology and therapeutic use". Clinical Cardiology. 13 (5): 349–59. doi:10.1002/clc.4960130509. PMID 2189614. S2CID 269453.
Li G, Zhang L (November 2018). "The role of mexiletine in the management of long QT syndrome". Journal of Electrocardiology. 51 (6): 1061–1065. doi:10.1016/j.jelectrocard.2018.08.035. PMID 30497731. S2CID 54167081.
Romman A, Salama-Hanna J, Dwivedi S (September 2018). "Mexiletine Usage in a Chronic Pain Clinic: Indications, Tolerability, and Side Effects". Pain Physician. 21 (5): E573–E579. doi:10.36076/ppj.2018.5.E573. PMID 30282405. S2CID 52917253.

drugbank.ca

"Mexiletine". www.drugbank.ca. Retrieved 2019-06-17.

espacenet.com

worldwide.espacenet.com

US 3954872, Koppe R, Kummer W, "1-(2{40 ,6{40 -Dimethyl-phenoxy)-2-amino-alkanes and salts thereof", issued 1976, assigned to Boehringer Sohn Ingelheim.

nice.org.uk

bnf.nice.org.uk

"Mexiletine". British National Formulary. NICE. Retrieved 2019-06-17.

nih.gov

pubmed.ncbi.nlm.nih.gov

Manolis AS, Deering TF, Cameron J, Estes NA (May 1990). "Mexiletine: pharmacology and therapeutic use". Clinical Cardiology. 13 (5): 349–59. doi:10.1002/clc.4960130509. PMID 2189614. S2CID 269453.
Li G, Zhang L (November 2018). "The role of mexiletine in the management of long QT syndrome". Journal of Electrocardiology. 51 (6): 1061–1065. doi:10.1016/j.jelectrocard.2018.08.035. PMID 30497731. S2CID 54167081.
Romman A, Salama-Hanna J, Dwivedi S (September 2018). "Mexiletine Usage in a Chronic Pain Clinic: Indications, Tolerability, and Side Effects". Pain Physician. 21 (5): E573–E579. doi:10.36076/ppj.2018.5.E573. PMID 30282405. S2CID 52917253.

semanticscholar.org

api.semanticscholar.org

Manolis AS, Deering TF, Cameron J, Estes NA (May 1990). "Mexiletine: pharmacology and therapeutic use". Clinical Cardiology. 13 (5): 349–59. doi:10.1002/clc.4960130509. PMID 2189614. S2CID 269453.
Li G, Zhang L (November 2018). "The role of mexiletine in the management of long QT syndrome". Journal of Electrocardiology. 51 (6): 1061–1065. doi:10.1016/j.jelectrocard.2018.08.035. PMID 30497731. S2CID 54167081.
Romman A, Salama-Hanna J, Dwivedi S (September 2018). "Mexiletine Usage in a Chronic Pain Clinic: Indications, Tolerability, and Side Effects". Pain Physician. 21 (5): E573–E579. doi:10.36076/ppj.2018.5.E573. PMID 30282405. S2CID 52917253.